68 related articles for article (PubMed ID: 6400300)
21. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
[TBL] [Abstract][Full Text] [Related]
22. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection.
Phalipon A; Tanguy M; Grandjean C; Guerreiro C; Bélot F; Cohen D; Sansonetti PJ; Mulard LA
J Immunol; 2009 Feb; 182(4):2241-7. PubMed ID: 19201878
[TBL] [Abstract][Full Text] [Related]
23. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
[TBL] [Abstract][Full Text] [Related]
24. Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208.
Kotloff KL; Pasetti MF; Barry EM; Nataro JP; Wasserman SS; Sztein MB; Picking WD; Levine MM
J Infect Dis; 2004 Nov; 190(10):1745-54. PubMed ID: 15499528
[TBL] [Abstract][Full Text] [Related]
25. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
Jennison AV; Roberts F; Verma NK
FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
[TBL] [Abstract][Full Text] [Related]
26. [Immunological studies in healthy children with Down's syndrome and in sick children].
Joó-Szabados T; Kaiser E; Ottó SZ
Ann Immunol Hung; 1973; 17():141-7. PubMed ID: 4282451
[No Abstract] [Full Text] [Related]
27. Dot-ELISA for seroepidemiological study of exposure to Shigella flexneri.
Suthienkul O; Poomchart A; Kositanont U; Siripanichgon K; Vathanophas K
Asian Pac J Allergy Immunol; 1993 Dec; 11(2):141-7. PubMed ID: 8080607
[TBL] [Abstract][Full Text] [Related]
28. Serodiagnosis of M. pneumoniae infections by enzyme-linked immunosorbent assay (ELISA).
Busolo F; Meloni GA
Yale J Biol Med; 1983; 56(5-6):517-21. PubMed ID: 6433571
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and protective efficacy offered by a ribosomal-based vaccine from Shigella flexneri 2a.
Shim DH; Chang SY; Park SM; Jang H; Carbis R; Czerkinsky C; Uematsu S; Akira S; Kweon MN
Vaccine; 2007 Jun; 25(25):4828-36. PubMed ID: 17507120
[TBL] [Abstract][Full Text] [Related]
30. [An immunoenzyme method for titrating antipneumococcal antibodies].
Mihalcu F; Stănescu L; Stănescu C; Dumitrescu A; Stefănescu M; Szegli G
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(1):55-8. PubMed ID: 3738365
[No Abstract] [Full Text] [Related]
31. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
Oaks EV; Turbyfill KR
Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
[TBL] [Abstract][Full Text] [Related]
32. Enzyme-linked immunosorbent assay for measurement of anti-Moraxella bovis antibodies.
Bishop B; Schurig GG; Troutt HF
Am J Vet Res; 1982 Aug; 43(8):1443-5. PubMed ID: 7049023
[TBL] [Abstract][Full Text] [Related]
33. Rational design and immunogenicity of liposome-based diepitope constructs: application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen.
Said Hassane F; Phalipon A; Tanguy M; Guerreiro C; Bélot F; Frisch B; Mulard LA; Schuber F
Vaccine; 2009 Aug; 27(39):5419-26. PubMed ID: 19559116
[TBL] [Abstract][Full Text] [Related]
34. [Expression of S.sonnei form I antigen gene and V.cholerae toxin B subunit gene in S.flexneri 2a strain and investigation of their immunoprotective response in mice].
Qian F; Rui X; Su G; Huang C
Yi Chuan Xue Bao; 1996; 23(4):322-8. PubMed ID: 8950856
[TBL] [Abstract][Full Text] [Related]
35. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
Rui X; Xu Y; Wan H; Su G; Huang C
Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
[TBL] [Abstract][Full Text] [Related]
36. Serological response to plasmid-encoded antigens in children and adults with shigellosis.
Echeverria P; Hanchalay S; Taylor DN
Diagn Microbiol Infect Dis; 1988 Jun; 10(2):75-80. PubMed ID: 3066570
[TBL] [Abstract][Full Text] [Related]
37. Enzyme-linked immunosorbent assay (ELISA) for antibodies to purified protein derivative of tuberculin (PPD). IgM-, IgA- and IgG- anti-PPD antibodies in active pulmonary tuberculosis.
Viljanen MK; Eskola J; Tala E
Eur J Respir Dis; 1982 May; 63(3):257-62. PubMed ID: 7095027
[TBL] [Abstract][Full Text] [Related]
38. [Construction and characterization of a live attenuated Shigella flexneri 2a vaccine strain, sf301 Delta virG and dsbA33G].
Yang XF; Zhou L; Zheng J; Si LS; Wang YL
Wei Sheng Wu Xue Bao; 2005 Oct; 45(5):748-52. PubMed ID: 16342769
[TBL] [Abstract][Full Text] [Related]
39. [Immunologic properties of coli surface antigen 6(CS6) of enterotoxigenic Escherichia coli and cholera toxin subunit B expressed in Shigella flexneri 2a strain T32].
Ying TY; Han ZZ; Feng EL; Wang HL; Zhang ZS; Su GF; Huang CF
Sheng Wu Gong Cheng Xue Bao; 2001 Jan; 17(1):29-33. PubMed ID: 11330183
[TBL] [Abstract][Full Text] [Related]
40. [Humoral response to selected antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis in the course of yersiniosis in humans. I. Occurrence of antibodies to Yersinia lipopolisacharydes and Yop proteins by ELISA].
Rastawicki W
Med Dosw Mikrobiol; 2006; 58(4):303-19. PubMed ID: 17642308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
